au.\*:("MOMIN, P")
Results 1 to 9 of 9
Selection :
Difference of Pseudomonas aeruginosa sensitivity to chloroxylenol according to the culture mediumDEVLEESCHOUWER, M. J; BOUSSARD, P; MOMIN, P et al.International journal of pharmaceutics. 1986, Vol 32, Num 1, pp 55-60, issn 0378-5173Article
A clinically relevant HIV-1 subunit vaccine protects rhesus macaques from in vivo passaged simian-human immunodeficiency virus infectionMOOIJ, P; VAN DER KOLK, M; VOSS, G et al.AIDS (London). 1998, Vol 12, Num 5, pp F15-F22, issn 0269-9370Article
Comparison of the sensitivity of Pseudomonas aeruginosa to disinfectants according to the growth conditionsDONY, J; DEVLEESCHOUWER, M. J; MOMIN, P et al.International journal of pharmaceutics. 1984, Vol 19, Num 2, pp 239-242, issn 0378-5173Article
Evolutionary relationships among bacterial carbamoyltransferasesTRICOT, C; DE COEN, J.-L; MOMIN, P et al.Journal of general microbiology. 1989, Vol 135, Num 9, pp 2453-2464, issn 0022-1287, 12 p.Article
Genetically Modified L3,7 and L2 Lipooligosaccharides from Neisseria meningitidis Serogroup B Confer a Broad Cross-Bactericidal ResponseWEYNANTS, V; DENOËL, P; WAUTERS, F et al.Infection and immunity. 2009, Vol 77, Num 5, pp 2084-2093, issn 0019-9567, 10 p.Article
A phase I safety and immunogenicity trial with the candidate malaria vaccine RTS, S/SBAS2 in semi-immune adults in the GambiaDOHERTY, J. F; PINDER, M; MOMIN, P et al.The American journal of tropical medicine and hygiene. 1999, Vol 61, Num 6, pp 865-868, issn 0002-9637Article
Long-term efficacy and immune responses following immunization with the RTS, S malaria vaccineSTOUTE, J. A; KESTER, K. E; LANAR, D. E et al.The Journal of infectious diseases. 1998, Vol 178, Num 4, pp 1139-1144, issn 0022-1899Article
Immunization against the murine malaria parasite Plasmodium yoelii using a recombinant protein with adjuvants developed for clinical useLING, I. T; OGUN, S. A; MOMIN, P et al.Vaccine. 1997, Vol 15, Num 14, pp 1562-1567, issn 0264-410XArticle
